This presenter / panel workshop hybrid will be anchored by two presentations examining the socioeconomic, medical and technological factors that will have a significant impact on mortality and our pricing over the next 20 years and beyond. These factors influence on continuing mortality improvements has been challenged of late with evidence in some western countries to be declining. This workshop will discuss whether significant mortality improvement will continue in Asia or whether varying experience of low improvements or deterioration. Specific topics such as genomics, technological advances, diabetes and Artificial Intelligence will be discussed, along with more traditional advances such as antibiotic resistance, pandemics, climate change, socio-economic
Dr Kamakhya Das, Partner Re
Dr K amakhya Das is the Chief Medical Underwriter, L&H, Asia Pac at PartnerRe. Over the last two decades, Dr Das has worked with both direct players and reinsu rers and contributed in the space of underwriting, claims, product development and strategy. His core strength has been around building dynamic underwriting solutions linked to distribution and customer behavior.
Ivan Lee, Swiss Re
Based in Singapore Ivan is Swiss Re Head of Life & Health Pricing SEA with over 10 years of experience in the re/insurance industry. Prior to this role, he was the Head of Life & Health Pricing Hong Kong & Taiwan.
Before joining Swiss Re Ivan was with a direct life insurer where he took on roles in both valuation and product pricing.
He is also known for his flexibility and creativity in product development and has a proven track record of successful product launches in the Hong Kong and Taiwan markets.
Contact Niki Park for more information.
020 7632 2152
This webinar will be 60 minutes incliuding time for Q&A. If you are unable to watch this webinar live, the session will be recorded and made available to watch on the VLE.
Nearest Public Transport